{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-11-11T12:23:39.176605+00:00",
  "news": [
    {
      "title": "#AHA25: Amgen’s cholesterol drug cuts first-time cardiovascular events by a quarter - Endpoints News",
      "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPM2dRc2VCSUxVYjIyVGJKZktuOXNISzYzbERjMXA5VGRQN1FrUEtZV0xFcHVNNTN2YUZvZFlwRXRrMWpXRXpVQXlzWlh2NUJjcTZlRkM2RmNicXBZcmVSZmxzLWpla3YtSklPeXhSOTRRak1QdXBkTFhCZTZKYm5IYW1Sc05hbXM3LTZQdEoxUmhIUkVNWmpOU0NlbDM2d0lfeUJuQlFzSQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipwFBVV95cUxPM2dRc2VCSUxVYjIyVGJKZktuOXNISzYzbERjMXA5VGRQN1FrUEtZV0xFcHVNNTN2YUZvZFlwRXRrMWpXRXpVQXlzWlh2NUJjcTZlRkM2RmNicXBZcmVSZmxzLWpla3YtSklPeXhSOTRRak1QdXBkTFhCZTZKYm5IYW1Sc05hbXM3LTZQdEoxUmhIUkVNWmpOU0NlbDM2d0lfeUJuQlFzSQ?oc=5\" target=\"_blank\">#AHA25: Amgen’s cholesterol drug cuts first-time cardiovascular events by a quarter</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
      "published": "2025-11-08T15:10:00+00:00",
      "source": "Endpoints News"
    },
    {
      "title": "CEO of drugmaker Amgen talks new results from cholesterol drug trial - CNBC",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNWnIyMTBzWlF3YTBDeVhfYlNYcnZBZ2RzQWpOamRxb3JSZU55MEdrUDRqdzZGT2o3VGNxa05Pc21hUThTZW9pS3lSWmFNWHZfaXJ0YmNodTVXNFhjM2hYZjBWeVpkSlVCakJHczRtOV94aWt2VlJQaU8zQWxCenZvZ1cyVmlJUDJSQUwzd0xZallhcldodk1jUjdnRk5RbkY3VUNPb29fWjLSAa4BQVVfeXFMTndXUncyNjdFRlpKT21TbEFRV2pMY1lDeTdEQ3NNcFlzLV9ScTJJZjFGdDRTWElDbHNGRXkwSkFMVFBxZVFQZzVDRWZmYVlJcEYxOVR6dGtKcEpOVDBlWXRSQVVxSGFnMUxxd2pMaTNmWkZGeTBCMVhGZ0lNbkFzNUlmcGZETUtFTXJkX01qblFRSTFHUG9kV3hVa29yWkNXTjFOZkxuNzY5SjZ6REl3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNWnIyMTBzWlF3YTBDeVhfYlNYcnZBZ2RzQWpOamRxb3JSZU55MEdrUDRqdzZGT2o3VGNxa05Pc21hUThTZW9pS3lSWmFNWHZfaXJ0YmNodTVXNFhjM2hYZjBWeVpkSlVCakJHczRtOV94aWt2VlJQaU8zQWxCenZvZ1cyVmlJUDJSQUwzd0xZallhcldodk1jUjdnRk5RbkY3VUNPb29fWjLSAa4BQVVfeXFMTndXUncyNjdFRlpKT21TbEFRV2pMY1lDeTdEQ3NNcFlzLV9ScTJJZjFGdDRTWElDbHNGRXkwSkFMVFBxZVFQZzVDRWZmYVlJcEYxOVR6dGtKcEpOVDBlWXRSQVVxSGFnMUxxd2pMaTNmWkZGeTBCMVhGZ0lNbkFzNUlmcGZETUtFTXJkX01qblFRSTFHUG9kV3hVa29yWkNXTjFOZkxuNzY5SjZ6REl3?oc=5\" target=\"_blank\">CEO of drugmaker Amgen talks new results from cholesterol drug trial</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2025-11-10T23:39:59+00:00",
      "source": "CNBC"
    },
    {
      "title": "Amgen cholesterol drug cuts risk of first cardiac event by 25% - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNNkhFaTFGNTVnS01wamZXLXpITVFSMV9wN0ZhWktwRlZZMDhsOTM2cGo4aHlOdGhhSjhONEZtbjdBT3UybERoT1NvQjlYYWpoeERsNGZMcmstSFlMT2ROTmlvUjN3NnBLZm1teUhjekpsNGp1d0o3bmZ6bzNURWVkMnU5RnlhWlRrNFBSSzVvSEt2NDJiMDJQODBlbll3T05zRElMN3BEbmVfd28xaGE5bUZOWnJxSGQ2M29UVDJLV0Nra2hoNTBhZjFB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxNNkhFaTFGNTVnS01wamZXLXpITVFSMV9wN0ZhWktwRlZZMDhsOTM2cGo4aHlOdGhhSjhONEZtbjdBT3UybERoT1NvQjlYYWpoeERsNGZMcmstSFlMT2ROTmlvUjN3NnBLZm1teUhjekpsNGp1d0o3bmZ6bzNURWVkMnU5RnlhWlRrNFBSSzVvSEt2NDJiMDJQODBlbll3T05zRElMN3BEbmVfd28xaGE5bUZOWnJxSGQ2M29UVDJLV0Nra2hoNTBhZjFB?oc=5\" target=\"_blank\">Amgen cholesterol drug cuts risk of first cardiac event by 25%</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-11-08T15:30:17+00:00",
      "source": "Reuters"
    },
    {
      "title": "Amgen’s cholesterol shot prevented first heart attacks and strokes, more detailed data affirm - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNWlZYNE1jbDZBQkJuelBaSnR0bFFqTXprSm9TSDJ5V2dVY0FYMVJwMGhndlFoaHFGOE5PNko3Qm5Ba2ZJdFdzckpFSVBfcWxNUEtWRmRidzlTalRZLUxzSjFSY2dNV25GMDRjSTF6VjVyUk1WZ3cyMmZCalloN3BWcDBVTnRKN2tMblE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxNWlZYNE1jbDZBQkJuelBaSnR0bFFqTXprSm9TSDJ5V2dVY0FYMVJwMGhndlFoaHFGOE5PNko3Qm5Ba2ZJdFdzckpFSVBfcWxNUEtWRmRidzlTalRZLUxzSjFSY2dNV25GMDRjSTF6VjVyUk1WZ3cyMmZCalloN3BWcDBVTnRKN2tMblE?oc=5\" target=\"_blank\">Amgen’s cholesterol shot prevented first heart attacks and strokes, more detailed data affirm</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-11-08T15:10:39+00:00",
      "source": "statnews.com"
    },
    {
      "title": "How Merck Is Taking On Amgen, Regeneron In Cholesterol - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxNZXYwRV80RDNwZk10aTVuc3Iza25tUXZDYXBMVXNmYmJfYUJ1YVFzZTBZMGtlYlZTVE54SVRjblR4MjlNMVQ2dWNTRnQ4R1VFVWt6RFVoMUJwUU1IUDdVYlA5TnJIQ0hULWFDRWZId0RUYktsRXlkNW9GLUlZWXA2Q19sQ0dBaDZPbEs4czlyUEIwQVdWTlctMnlBT0dBQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxNZXYwRV80RDNwZk10aTVuc3Iza25tUXZDYXBMVXNmYmJfYUJ1YVFzZTBZMGtlYlZTVE54SVRjblR4MjlNMVQ2dWNTRnQ4R1VFVWt6RFVoMUJwUU1IUDdVYlA5TnJIQ0hULWFDRWZId0RUYktsRXlkNW9GLUlZWXA2Q19sQ0dBaDZPbEs4czlyUEIwQVdWTlctMnlBT0dBQQ?oc=5\" target=\"_blank\">How Merck Is Taking On Amgen, Regeneron In Cholesterol</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2025-11-08T19:30:00+00:00",
      "source": "Investor's Business Daily"
    },
    {
      "title": "Amgen Inc. Just Beat EPS By 128%: Here's What Analysts Think Will Happen Next - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMieEFVX3lxTE52Z09RVlA2WG9KOTB2RXFYbmJfdWVZR3lfb1hscGFvV0JuZGtzMzFhLVpxUE5JaTVkay1BNWVwc2kxcFNtUkF5UGZldVFrV3Rla2x6OWZTQ0gwb3Z6Z1lEWVpzdEc0RGhNZTAtd1oyWVlhSFN1a0tpSA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMieEFVX3lxTE52Z09RVlA2WG9KOTB2RXFYbmJfdWVZR3lfb1hscGFvV0JuZGtzMzFhLVpxUE5JaTVkay1BNWVwc2kxcFNtUkF5UGZldVFrV3Rla2x6OWZTQ0gwb3Z6Z1lEWVpzdEc0RGhNZTAtd1oyWVlhSFN1a0tpSA?oc=5\" target=\"_blank\">Amgen Inc. Just Beat EPS By 128%: Here's What Analysts Think Will Happen Next</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-08T12:34:06+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen: Buy This Cheap Biotech Leader - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNTm5kcWRzS2dhZWlNU09lLXBDTGxlSmd0SnRRbFF4QnVEaWRqMlRUaDB5bUxhc2RFeml1U09CZl9PSjIwdnY4NnUxSkdlWkNaSnRnZzZhSkdQTy1QTGxFUU5JUnVUeFRGNHVMcXR4d3d3MFEtNnNySF9teG5PUUp3NWJ3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxNTm5kcWRzS2dhZWlNU09lLXBDTGxlSmd0SnRRbFF4QnVEaWRqMlRUaDB5bUxhc2RFeml1U09CZl9PSjIwdnY4NnUxSkdlWkNaSnRnZzZhSkdQTy1QTGxFUU5JUnVUeFRGNHVMcXR4d3d3MFEtNnNySF9teG5PUUp3NWJ3?oc=5\" target=\"_blank\">Amgen: Buy This Cheap Biotech Leader</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-11-08T05:11:07+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Amgen’s Repatha Cuts Risk of First Heart Attack by 36% in Phase III Trial - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQaC13YU5WWXhqVGdFYzJRclU3NS1LUjg5US1fNGxFZzBmc0pNNmR3X1F2RHM5SlJhcVczQ0QxMWdudl9rd3R0clVLUmU2QXJfcGdSYThWOV9qRGhyN2ExcG1SSnRYVC1wcFNBanQ5aVRqZDFpM3E4UFZNNUJhMTNVc0QwOWpRMmFRa05ab0xBWW9EeU5XMjJnbmphcXFwVlJxeG1qQURZLXk5R0FyZVpadXdDMA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiswFBVV95cUxQaC13YU5WWXhqVGdFYzJRclU3NS1LUjg5US1fNGxFZzBmc0pNNmR3X1F2RHM5SlJhcVczQ0QxMWdudl9rd3R0clVLUmU2QXJfcGdSYThWOV9qRGhyN2ExcG1SSnRYVC1wcFNBanQ5aVRqZDFpM3E4UFZNNUJhMTNVc0QwOWpRMmFRa05ab0xBWW9EeU5XMjJnbmphcXFwVlJxeG1qQURZLXk5R0FyZVpadXdDMA?oc=5\" target=\"_blank\">Amgen’s Repatha Cuts Risk of First Heart Attack by 36% in Phase III Trial</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-10T14:05:55+00:00",
      "source": "BioSpace"
    }
  ],
  "product_launches": [
    {
      "title": "AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance - TradingView",
      "link": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNN09XMkFVU05lZ0ZfVnZnbzkzU3NuNklBWEhsUWtkbVpTOHhHVHEzbk5PSEpGVEY1dUFjLTFLY3U5ZUg1RlhWZm1MR2hqNEd2ZWotTmx5T20wZjhseDBNcTdkdXlELXJvZjRZUVpDR1VXYTdtWmxHX3ZRLXFnRFBIb3VfWk4wSk5fV0ZoNGVSNFNhbkZqUHBhZXc2a0lQZ2Exa2w4eVJZakRFSk5uczBZcmJvSnlXVWRVNHQyV1M0MDZXd2l6X3dFbk5ua0p2UE1VUV9HV0xFS1ppLXZEdFJmRllmR1A1QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNN09XMkFVU05lZ0ZfVnZnbzkzU3NuNklBWEhsUWtkbVpTOHhHVHEzbk5PSEpGVEY1dUFjLTFLY3U5ZUg1RlhWZm1MR2hqNEd2ZWotTmx5T20wZjhseDBNcTdkdXlELXJvZjRZUVpDR1VXYTdtWmxHX3ZRLXFnRFBIb3VfWk4wSk5fV0ZoNGVSNFNhbkZqUHBhZXc2a0lQZ2Exa2w4eVJZakRFSk5uczBZcmJvSnlXVWRVNHQyV1M0MDZXd2l6X3dFbk5ua0p2UE1VUV9HV0xFS1ppLXZEdFJmRllmR1A1QQ?oc=5\" target=\"_blank\">AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>",
      "published": "2025-11-05T13:36:48+00:00",
      "source": "TradingView"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-11-10",
      "close": 323.6600036621094
    },
    "history": [
      {
        "date": "2025-10-31",
        "close": 298.42999267578125
      },
      {
        "date": "2025-11-03",
        "close": 296.29998779296875
      },
      {
        "date": "2025-11-04",
        "close": 296.70001220703125
      },
      {
        "date": "2025-11-05",
        "close": 319.8599853515625
      },
      {
        "date": "2025-11-06",
        "close": 315.5899963378906
      },
      {
        "date": "2025-11-07",
        "close": 320.20001220703125
      },
      {
        "date": "2025-11-10",
        "close": 323.6600036621094
      }
    ],
    "name": "Amgen Inc."
  }
}